RenewalBio
PrivateLast Round
Seed
Nov 11, 2025
Total Funding Raised
$400,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RenewalBio operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in November 2025.
RenewalBio is a biotechnology company that develops a synthetic-embryo and stem-cell therapeutics platform intended to generate transplantable tissues and rejuvenated cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RenewalBio Comparables
Compare RenewalBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GC Therapeutics | 81% | |
| LyGenesis | 79% | |
| Stratus Therapeutics | 78% |
For institutional investors. Book with your work email.
RenewalBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RenewalBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| Gaingels | Seed |
| Calm Ventures | Seed |
| YZi Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 51% MoM, reaching 2.4K.
- Apr 16, 2026
Monthly visitors increased 281% MoM, reaching 666.
For institutional investors. Book with your work email.
RenewalBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RenewalBio's valuation, stock price, and market status.
Is RenewalBio a public or private company?
RenewalBio is a private company.
What is the current stock price of RenewalBio?
RenewalBio is a private company, so its shares have no public market price. Caplight tracks RenewalBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RenewalBio worth (valuation)?
Valuation information for RenewalBio is not publicly available.
Can I buy RenewalBio stock?
RenewalBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RenewalBio's last funding round?
RenewalBio's most recent funding round was Seed on November 11, 2025.
Who are the main investors in RenewalBio?
Key investors in RenewalBio include YZi Labs.
Will RenewalBio IPO soon?
No public IPO plans have been announced for RenewalBio.
How can I track RenewalBio secondary market activity?
Caplight tracks bids, offers, and trades in RenewalBio's shares on secondary markets.